April 04, 2021
1 min learn
FX Options introduced in a press launch that it obtained FDA clearance for its Easytech Stemless Anatomic shoulder prosthesis, meant to deal with painful and disabled shoulder joints.
Based on the discharge, the machine is the one stemless shoulder prosthesis with main peripheral fixation available on the market.
“It is a very thrilling addition to our complete portfolio and can enable us to compete within the stemless market with an amazing prosthesis that, with its main peripheral fixation, ought to give us a aggressive benefit and probably enhance affected person outcomes with a bone sparing machine,” Baptiste Martin, CEO of FX Shoulder, stated within the launch.
Based on the discharge, the Easytech Anchor base permits the machine to suit contained in the cortical bone, the place bone high quality is perfect for fixation.
“Since its launch in Europe, the Easytech Stemless Anatomic has turn into the first alternative of surgeons for his or her anatomic complete shoulder replacements with demonstrated wonderful medical success,” in line with the discharge.